URGN

UroGen Pharma develops medicines to treat bladder and urinary tract cancers. The company sells Zusduri, a drug that delivers chemotherapy directly into the bladder to treat early-stage bladder cancer, and Jelmyto, which treats cancer in the upper urinary tract. UroGen is also testing several experimental medicines in clinical trials, including treatments designed for different stages and types of bladder cancer. The company uses a special gel technology that allows drugs to stay in the bladder or urinary tract longer, which helps the medicine work better.